These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 28951089)
1. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Hamstra DA; Mariados N; Sylvester J; Shah D; Gross E; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Daignault-Newton S; Fischer-Valuck BW; Chundury A; Gay HA; Bosch W; Michalski J Pract Radiat Oncol; 2018; 8(1):e7-e15. PubMed ID: 28951089 [TBL] [Abstract][Full Text] [Related]
2. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Hamstra DA; Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Daignault-Newton S; Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):976-985. PubMed ID: 28209443 [TBL] [Abstract][Full Text] [Related]
3. A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. Seymour ZA; Pinkawa M; Daignault-Newton S; Bosch W; Michalski JM; Gay H; Hamstra DA Front Oncol; 2023; 13():1239104. PubMed ID: 37886176 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life. Seymour ZA; Hamstra DA; Daignault-Newton S; Bosch W; Michalski J; Gay HA; Pinkawa M BJU Int; 2020 Sep; 126(3):367-372. PubMed ID: 32333714 [TBL] [Abstract][Full Text] [Related]
5. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data. Karsh LI; Gross ET; Pieczonka CM; Aliotta PJ; Skomra CJ; Ponsky LE; Nieh PT; Han M; Hamstra DA; Shore ND Urology; 2018 May; 115():39-44. PubMed ID: 29174940 [TBL] [Abstract][Full Text] [Related]
10. Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses. Abuodeh YA; Naghavi AO; Juan TH; Ma Z; Wilder RB Int Braz J Urol; 2017; 43(4):628-637. PubMed ID: 28379660 [TBL] [Abstract][Full Text] [Related]
11. Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial. Quinn TJ; Daignault-Newton S; Bosch W; Mariados N; Sylvester J; Shah D; Gross E; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; DeWeese T; Gay HA; Michalski J; Hamstra DA Pract Radiat Oncol; 2020; 10(3):186-194. PubMed ID: 31978591 [TBL] [Abstract][Full Text] [Related]
12. Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer. Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Kiss A; Mamedov A; Deabreu A Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):617-23. PubMed ID: 22079736 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. Shaikh T; Li T; Handorf EA; Johnson ME; Wang LS; Hallman MA; Greenberg RE; Price RA; Uzzo RG; Ma C; Chen D; Geynisman DM; Pollack A; Horwitz EM Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):722-731. PubMed ID: 28244407 [TBL] [Abstract][Full Text] [Related]
14. Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis. Miller LE; Efstathiou JA; Bhattacharyya SK; Payne HA; Woodward E; Pinkawa M JAMA Netw Open; 2020 Jun; 3(6):e208221. PubMed ID: 32585020 [TBL] [Abstract][Full Text] [Related]
15. Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer. Kao J; Turian J; Meyers A; Hamilton RJ; Smith B; Vijayakumar S; Jani AB Br J Radiol; 2004 Feb; 77(914):129-36. PubMed ID: 15010385 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis. King MT; Svatos M; Chell EW; Pigrish V; Miller K; Low DA; Orio PF Pract Radiat Oncol; 2024; 14(3):e214-e219. PubMed ID: 38043644 [TBL] [Abstract][Full Text] [Related]
17. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis. Pinkawa M; Piroth MD; Holy R; Escobar-Corral N; Caffaro M; Djukic V; Klotz J; Eble MJ Strahlenther Onkol; 2012 Oct; 188(10):917-25. PubMed ID: 22933033 [TBL] [Abstract][Full Text] [Related]
18. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584 [TBL] [Abstract][Full Text] [Related]
19. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819 [TBL] [Abstract][Full Text] [Related]
20. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Evans JR; Zhao S; Daignault S; Sanda MG; Michalski J; Sandler HM; Kuban DA; Ciezki J; Kaplan ID; Zietman AL; Hembroff L; Feng FY; Suy S; Skolarus TA; McLaughlin PW; Wei JT; Dunn RL; Finkelstein SE; Mantz CA; Collins SP; Hamstra DA; Radiother Oncol; 2015 Aug; 116(2):179-84. PubMed ID: 26276528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]